Propanc Biopharma announced new insights about how cancer stem cells can resist standard treatments, become more aggressive and spread rapidly.
Algae Dynamics signed a memorandum of understanding with licensed producer Bonify, in order to supply raw cannabis plant material for oil sale and research.
PUF Ventures announced it elected an early termination of their third party mortgage debt related to its purchase of private Ontario cannabis company AAA Heidelberg.
By Jocelyn Aspa
PyroGenesis Canada (TSXV:PYR) has announced further to its press release from March 30, 2017, it signed its first contract and received the down payment for an order of titanium power and Inconel from a conglomerate.
As quoted in the press release:
“As previously announced on March 30, 2017, we did not expect
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of
Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA’s ASD-002, which is being developed to treat a rare pediatric nonverbal disorder.
Clearside Biomedical has finalized the enrollment for its clinical trial of CLS-TA in treating diabetic macular edema.
Alset Energy Corp. (TSXV:ION) is pleased to announce that drilling has commenced on the La Salada salar in Zacatecas, Mexico. The exploration program includes two deep holes to test for brine horizons, sediment composition and depth to basement; followed by a shallow subsurface sampling program. Material from this work will
By Pia Rivera
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce the appointment of Dr. Amy Ripka and Dr. Rick Panicucci to its board of scientific advisors.
Alset Energy Corp. (TSXV:ION) is pleased to announce that, subject to regulatory approval, it will accelerate the exercise of its earn in option to acquire the Mexican salar project. Alset and MKG Mining have agreed to amend the original agreement that would have taken a further 5 years for Alset
By Shelly Kumar
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF) (the “Company” or “3DS”), is pleased to announce the appointment of Dr. Kevin Little, subject to approval of the TSX Venture Exchange, a leading biomedical scientist and corporate executive, as its new Chief Scientific Officer (“CSO”), effective immediately. In this role, Dr. Little will oversee the
Cytori Therapeutics received approval from the US Food and Drug Administration for a burn clinical trial using the Cytori Cell Therapy.
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced the Company closed a private placement with proceeds of $4,349,953.50. Laidlaw & Co (UK) Ltd. in New
By Pia Rivera
Natcore Technology (TSXV:NXT,OTCQB:NTCXF,FWB:8NT) has signed a joint development agreement with Coveme spa, the Italian company that is a leading innovator in the manufacture and conversion of polyester films.
Natcore has recently developed the Natcore Foil Cell, which combines a revolutionary laser process with a novel metallization strategy, thus enabling high-efficiency cell